GE HealthCare Technologies GEHC
NASDAQ GEHC
$74.76 +0.14 (+0.19%)
At close: Aug 20, 2026 · 2:06 PM UTC

GE HealthCare Technologies (GEHC) Change in Account Payables (2022 - 2026)

GE HealthCare Technologies' (GEHC) quarterly Change in Account Payables came in at -$200.0 million in Q2 2026, up 22.78% YoY from -$162.9 million in Q2 2025, and down 190.5% on a QoQ basis from $221.0 million in Q1 2026.

GE HealthCare Technologies (GEHC) Change in Account Payables (2022 - 2026) Analysis & Trends

GE HealthCare Technologies (GEHC) has 5 years of Change in Account Payables data on file, last reported at -$200.0 million in Q2 2026.

  • Quarterly Change in Account Payables rose 22.78% year-over-year to -$200.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $224.0 million (up 409.09% YoY) and the FY2025 annual result came in at $90.0 million, up 50.0% from the prior year.
  • Change in Account Payables eased to -$200.0 million in Q2 2026, from $221.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $319.0 million in Q1 2022 to a low of -$259.0 million in Q2 2025.
  • A 5-year average of $30.7 million and a median of $30.5 million in 2024 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2023 — Change in Account Payables slumped 243.24% — and 2024, when it surged 1914.29%.
  • Tracing GEHC's Change in Account Payables over 5 years: stood at $112.0 million in 2022, then slumped by 106.25% to -$7.0 million in 2023, then surged by 1914.29% to $127.0 million in 2024, then soared by 64.57% to $209.0 million in 2025, then sank by 195.69% to -$200.0 million in 2026.
  • The last three Change in Account Payables figures came in at -$200.0 million (Q2 2026), $221.0 million (Q1 2026), and $209.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 199.45 Bn 193.85 Bn 7.27 Bn -
2 Stryker 127.62 Bn 124.14 Bn 4.50 Bn 71.00 Mn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn -
4 Boston Scientific 73.41 Bn 72.87 Bn 3.85 Bn -
5 Edwards Lifesciences 51.89 Bn 47.64 Bn 1.35 Bn -
6 Dexcom 34.33 Bn 32.38 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.87 Bn 31.76 Bn 2.18 Bn -200.00 Mn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 4.30 Mn
10 Zimmer Biomet Holdings 19.24 Bn 18.83 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -200.00 Mn
Jun 30, 2026 -200.00 Mn
Mar 31, 2026 221.00 Mn
Mar 31, 2026 221.00 Mn
Dec 31, 2025 209.00 Mn
Dec 31, 2025 209.00 Mn
Sep 30, 2025 -6.00 Mn
Sep 30, 2025 -6.00 Mn
Jun 30, 2025 -259.00 Mn
Jun 30, 2025 -259.00 Mn
Mar 31, 2025 146.00 Mn
Mar 31, 2025 146.00 Mn
Dec 31, 2024 127.00 Mn
Dec 31, 2024 127.00 Mn
Sep 30, 2024 30.00 Mn
Sep 30, 2024 30.00 Mn
Jun 30, 2024 -128.00 Mn
Jun 30, 2024 -128.00 Mn
Mar 31, 2024 31.00 Mn
Mar 31, 2024 31.00 Mn